Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis

M. W. Schuster, E. Anaissie, D. Hurd, W. Bensinger, J. Mason, J. McCarty, R. Rifkin, R. Maziarz, Y. Halvorsen, V. Annino, W. Hahne

Research output: Contribution to journalArticle

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)58-59
Number of pages2
JournalJournal of Supportive Oncology
Volume5
Issue number4 SUPPL. 2
StatePublished - Apr 1 2007

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this

Schuster, M. W., Anaissie, E., Hurd, D., Bensinger, W., Mason, J., McCarty, J., Rifkin, R., Maziarz, R., Halvorsen, Y., Annino, V., & Hahne, W. (2007). Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis. Journal of Supportive Oncology, 5(4 SUPPL. 2), 58-59.